Literature DB >> 29287996

Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens.

Robert K Abbott1, Jeong Hyun Lee1, Sergey Menis2, Patrick Skog3, Meghan Rossi1, Takayuki Ota3, Daniel W Kulp4, Deepika Bhullar3, Oleksandr Kalyuzhniy2, Colin Havenar-Daughton1, William R Schief5, David Nemazee6, Shane Crotty7.   

Abstract

How precursor frequencies and antigen affinities impact interclonal B cell competition is a particularly relevant issue for candidate germline-targeting HIV vaccine designs because of the in vivo rarity of naive B cells that recognize broadly neutralizing epitopes. Knowing the frequencies and affinities of HIV-specific VRC01-class naive human B cells, we transferred B cells with germline VRC01 B cell receptors into congenic recipients to elucidate the roles of precursor frequency, antigen affinity, and avidity on B cell responses following immunization. All three factors were interdependently limiting for competitive success of VRC01-class B cells. In physiological high-affinity conditions using a multivalent immunogen, rare VRC01-class B cells successfully competed in germinal centers (GC), underwent extensive somatic hypermutation, and differentiated into memory B cells. The data reveal dominant influences of precursor frequency, affinity, and avidity for interclonal GC competition and indicate that germline-targeting immunogens can overcome these challenges with high-affinity multimeric designs.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV; T follicular helper (Tfh); VRC01; affinity maturation; antibody; avidity; humoral immunity; immunoglobulins; interclonal competition; vaccine

Mesh:

Substances:

Year:  2017        PMID: 29287996      PMCID: PMC5773359          DOI: 10.1016/j.immuni.2017.11.023

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  125 in total

Review 1.  Minding the gap: The impact of B-cell tolerance on the microbial antibody repertoire.

Authors:  Joel Finney; Akiko Watanabe; Garnett Kelsoe; Masayuki Kuraoka
Journal:  Immunol Rev       Date:  2019-09-27       Impact factor: 12.988

Review 2.  Advancing an HIV vaccine; advancing vaccinology.

Authors:  Dennis R Burton
Journal:  Nat Rev Immunol       Date:  2019-02       Impact factor: 53.106

3.  Outflanking immunodominance to target subdominant broadly neutralizing epitopes.

Authors:  Davide Angeletti; Ivan Kosik; Jefferson J S Santos; William T Yewdell; Carolyn M Boudreau; Vamsee V A Mallajosyula; Madeleine C Mankowski; Michael Chambers; Madhu Prabhakaran; Heather D Hickman; Adrian B McDermott; Galit Alter; Jayanta Chaudhuri; Jonathan W Yewdell
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-18       Impact factor: 11.205

Review 4.  Rationalizing Random Walks: Replicating Protective Antibody Trajectories.

Authors:  Jennifer L Remmel; Margaret E Ackerman
Journal:  Trends Immunol       Date:  2021-01-26       Impact factor: 16.687

Review 5.  Basics of memory B-cell responses: lessons from and for the real world.

Authors:  Rachel Wong; Deepta Bhattacharya
Journal:  Immunology       Date:  2018-11-29       Impact factor: 7.397

6.  Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus.

Authors:  Maya Sangesland; Larance Ronsard; Samuel W Kazer; Julia Bals; Seyhan Boyoglu-Barnum; Ashraf S Yousif; Ralston Barnes; Jared Feldman; Maricel Quirindongo-Crespo; Patrick M McTamney; Daniel Rohrer; Nils Lonberg; Bryce Chackerian; Barney S Graham; Masaru Kanekiyo; Alex K Shalek; Daniel Lingwood
Journal:  Immunity       Date:  2019-09-25       Impact factor: 31.745

Review 7.  T Follicular Helper Cell Biology: A Decade of Discovery and Diseases.

Authors:  Shane Crotty
Journal:  Immunity       Date:  2019-05-21       Impact factor: 31.745

8.  Antibody Affinity Shapes the Choice between Memory and Germinal Center B Cell Fates.

Authors:  Charlotte Viant; Georg H J Weymar; Amelia Escolano; Spencer Chen; Harald Hartweger; Melissa Cipolla; Anna Gazumyan; Michel C Nussenzweig
Journal:  Cell       Date:  2020-10-29       Impact factor: 41.582

Review 9.  Subdominance in Antibody Responses: Implications for Vaccine Development.

Authors:  Gunnar Lindahl
Journal:  Microbiol Mol Biol Rev       Date:  2020-11-25       Impact factor: 11.056

10.  Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies.

Authors:  Hongying Duan; Xuejun Chen; Jeffrey C Boyington; Cheng Cheng; Yi Zhang; Alexander J Jafari; Tyler Stephens; Yaroslav Tsybovsky; Oleksandr Kalyuzhniy; Peng Zhao; Sergey Menis; Martha C Nason; Erica Normandin; Maryam Mukhamedova; Brandon J DeKosky; Lance Wells; William R Schief; Ming Tian; Frederick W Alt; Peter D Kwong; John R Mascola
Journal:  Immunity       Date:  2018-07-31       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.